Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Buprenorphine Transdermal Patches Market Growth 2022-2028

  • LP 4872173
  • 74 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Buprenorphine Transdermal Patches will have significant change from previous year. According to our (LP Information) latest study, the global Buprenorphine Transdermal Patches market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Buprenorphine Transdermal Patches market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Buprenorphine Transdermal Patches market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Buprenorphine Transdermal Patches market, reaching US$ million by the year 2028. As for the Europe Buprenorphine Transdermal Patches landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Buprenorphine Transdermal Patches players cover Grunenthal, PurduePharma, Luye Pharma, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Transdermal Patches market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

5mcg/h

7.5mcg/h

10mcg/h

15 mcg/h

20 mcg/h

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Relieve Cancer Pain

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Grunenthal

PurduePharma

Luye Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Buprenorphine Transdermal Patches Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Buprenorphine Transdermal Patches by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Buprenorphine Transdermal Patches by Country/Region, 2017, 2022 & 2028

2.2 Buprenorphine Transdermal Patches Segment by Type

2.2.1 5mcg/h

2.2.2 7.5mcg/h

2.2.3 10mcg/h

2.2.4 15 mcg/h

2.2.5 20 mcg/h

2.3 Buprenorphine Transdermal Patches Sales by Type

2.3.1 Global Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)

2.3.2 Global Buprenorphine Transdermal Patches Revenue and Market Share by Type (2017-2022)

2.3.3 Global Buprenorphine Transdermal Patches Sale Price by Type (2017-2022)

2.4 Buprenorphine Transdermal Patches Segment by Application

2.4.1 Relieve Cancer Pain

2.4.2 Other

2.5 Buprenorphine Transdermal Patches Sales by Application

2.5.1 Global Buprenorphine Transdermal Patches Sale Market Share by Application (2017-2022)

2.5.2 Global Buprenorphine Transdermal Patches Revenue and Market Share by Application (2017-2022)

2.5.3 Global Buprenorphine Transdermal Patches Sale Price by Application (2017-2022)

3 Global Buprenorphine Transdermal Patches by Company

3.1 Global Buprenorphine Transdermal Patches Breakdown Data by Company

3.1.1 Global Buprenorphine Transdermal Patches Annual Sales by Company (2020-2022)

3.1.2 Global Buprenorphine Transdermal Patches Sales Market Share by Company (2020-2022)

3.2 Global Buprenorphine Transdermal Patches Annual Revenue by Company (2020-2022)

3.2.1 Global Buprenorphine Transdermal Patches Revenue by Company (2020-2022)

3.2.2 Global Buprenorphine Transdermal Patches Revenue Market Share by Company (2020-2022)

3.3 Global Buprenorphine Transdermal Patches Sale Price by Company

3.4 Key Manufacturers Buprenorphine Transdermal Patches Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Buprenorphine Transdermal Patches Product Location Distribution

3.4.2 Players Buprenorphine Transdermal Patches Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Buprenorphine Transdermal Patches by Geographic Region

4.1 World Historic Buprenorphine Transdermal Patches Market Size by Geographic Region (2017-2022)

4.1.1 Global Buprenorphine Transdermal Patches Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Buprenorphine Transdermal Patches Annual Revenue by Geographic Region

4.2 World Historic Buprenorphine Transdermal Patches Market Size by Country/Region (2017-2022)

4.2.1 Global Buprenorphine Transdermal Patches Annual Sales by Country/Region (2017-2022)

4.2.2 Global Buprenorphine Transdermal Patches Annual Revenue by Country/Region

4.3 Americas Buprenorphine Transdermal Patches Sales Growth

4.4 APAC Buprenorphine Transdermal Patches Sales Growth

4.5 Europe Buprenorphine Transdermal Patches Sales Growth

4.6 Middle East & Africa Buprenorphine Transdermal Patches Sales Growth

5 Americas

5.1 Americas Buprenorphine Transdermal Patches Sales by Country

5.1.1 Americas Buprenorphine Transdermal Patches Sales by Country (2017-2022)

5.1.2 Americas Buprenorphine Transdermal Patches Revenue by Country (2017-2022)

5.2 Americas Buprenorphine Transdermal Patches Sales by Type

5.3 Americas Buprenorphine Transdermal Patches Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Buprenorphine Transdermal Patches Sales by Region

6.1.1 APAC Buprenorphine Transdermal Patches Sales by Region (2017-2022)

6.1.2 APAC Buprenorphine Transdermal Patches Revenue by Region (2017-2022)

6.2 APAC Buprenorphine Transdermal Patches Sales by Type

6.3 APAC Buprenorphine Transdermal Patches Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Buprenorphine Transdermal Patches by Country

7.1.1 Europe Buprenorphine Transdermal Patches Sales by Country (2017-2022)

7.1.2 Europe Buprenorphine Transdermal Patches Revenue by Country (2017-2022)

7.2 Europe Buprenorphine Transdermal Patches Sales by Type

7.3 Europe Buprenorphine Transdermal Patches Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Buprenorphine Transdermal Patches by Country

8.1.1 Middle East & Africa Buprenorphine Transdermal Patches Sales by Country (2017-2022)

8.1.2 Middle East & Africa Buprenorphine Transdermal Patches Revenue by Country (2017-2022)

8.2 Middle East & Africa Buprenorphine Transdermal Patches Sales by Type

8.3 Middle East & Africa Buprenorphine Transdermal Patches Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Buprenorphine Transdermal Patches

10.3 Manufacturing Process Analysis of Buprenorphine Transdermal Patches

10.4 Industry Chain Structure of Buprenorphine Transdermal Patches

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Buprenorphine Transdermal Patches Distributors

11.3 Buprenorphine Transdermal Patches Customer

12 World Forecast Review for Buprenorphine Transdermal Patches by Geographic Region

12.1 Global Buprenorphine Transdermal Patches Market Size Forecast by Region

12.1.1 Global Buprenorphine Transdermal Patches Forecast by Region (2023-2028)

12.1.2 Global Buprenorphine Transdermal Patches Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Buprenorphine Transdermal Patches Forecast by Type

12.7 Global Buprenorphine Transdermal Patches Forecast by Application

13 Key Players Analysis

13.1 Grunenthal

13.1.1 Grunenthal Company Information

13.1.2 Grunenthal Buprenorphine Transdermal Patches Product Offered

13.1.3 Grunenthal Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Grunenthal Main Business Overview

13.1.5 Grunenthal Latest Developments

13.2 PurduePharma

13.2.1 PurduePharma Company Information

13.2.2 PurduePharma Buprenorphine Transdermal Patches Product Offered

13.2.3 PurduePharma Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 PurduePharma Main Business Overview

13.2.5 PurduePharma Latest Developments

13.3 Luye Pharma

13.3.1 Luye Pharma Company Information

13.3.2 Luye Pharma Buprenorphine Transdermal Patches Product Offered

13.3.3 Luye Pharma Buprenorphine Transdermal Patches Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Luye Pharma Main Business Overview

13.3.5 Luye Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Buprenorphine Transdermal Patches Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Buprenorphine Transdermal Patches Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 5mcg/h

Table 4. Major Players of 7.5mcg/h

Table 5. Major Players of 10mcg/h

Table 6. Major Players of 15 mcg/h

Table 7. Major Players of 20 mcg/h

Table 8. Global Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)

Table 9. Global Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)

Table 10. Global Buprenorphine Transdermal Patches Revenue by Type (2017-2022) & ($ million)

Table 11. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2017-2022)

Table 12. Global Buprenorphine Transdermal Patches Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)

Table 14. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)

Table 15. Global Buprenorphine Transdermal Patches Revenue by Application (2017-2022)

Table 16. Global Buprenorphine Transdermal Patches Revenue Market Share by Application (2017-2022)

Table 17. Global Buprenorphine Transdermal Patches Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global Buprenorphine Transdermal Patches Sales by Company (2020-2022) & (K Units)

Table 19. Global Buprenorphine Transdermal Patches Sales Market Share by Company (2020-2022)

Table 20. Global Buprenorphine Transdermal Patches Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Buprenorphine Transdermal Patches Revenue Market Share by Company (2020-2022)

Table 22. Global Buprenorphine Transdermal Patches Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers Buprenorphine Transdermal Patches Producing Area Distribution and Sales Area

Table 24. Players Buprenorphine Transdermal Patches Products Offered

Table 25. Buprenorphine Transdermal Patches Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Buprenorphine Transdermal Patches Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Buprenorphine Transdermal Patches Sales Market Share Geographic Region (2017-2022)

Table 30. Global Buprenorphine Transdermal Patches Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Buprenorphine Transdermal Patches Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Buprenorphine Transdermal Patches Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Buprenorphine Transdermal Patches Sales Market Share by Country/Region (2017-2022)

Table 34. Global Buprenorphine Transdermal Patches Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Buprenorphine Transdermal Patches Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Buprenorphine Transdermal Patches Sales by Country (2017-2022) & (K Units)

Table 37. Americas Buprenorphine Transdermal Patches Sales Market Share by Country (2017-2022)

Table 38. Americas Buprenorphine Transdermal Patches Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Buprenorphine Transdermal Patches Revenue Market Share by Country (2017-2022)

Table 40. Americas Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)

Table 41. Americas Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)

Table 42. Americas Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)

Table 43. Americas Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)

Table 44. APAC Buprenorphine Transdermal Patches Sales by Region (2017-2022) & (K Units)

Table 45. APAC Buprenorphine Transdermal Patches Sales Market Share by Region (2017-2022)

Table 46. APAC Buprenorphine Transdermal Patches Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Buprenorphine Transdermal Patches Revenue Market Share by Region (2017-2022)

Table 48. APAC Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)

Table 49. APAC Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)

Table 50. APAC Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)

Table 51. APAC Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)

Table 52. Europe Buprenorphine Transdermal Patches Sales by Country (2017-2022) & (K Units)

Table 53. Europe Buprenorphine Transdermal Patches Sales Market Share by Country (2017-2022)

Table 54. Europe Buprenorphine Transdermal Patches Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Buprenorphine Transdermal Patches Revenue Market Share by Country (2017-2022)

Table 56. Europe Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)

Table 57. Europe Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)

Table 58. Europe Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)

Table 59. Europe Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Buprenorphine Transdermal Patches Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Buprenorphine Transdermal Patches Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Buprenorphine Transdermal Patches Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Buprenorphine Transdermal Patches Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Buprenorphine Transdermal Patches Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Buprenorphine Transdermal Patches

Table 69. Key Market Challenges & Risks of Buprenorphine Transdermal Patches

Table 70. Key Industry Trends of Buprenorphine Transdermal Patches

Table 71. Buprenorphine Transdermal Patches Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Buprenorphine Transdermal Patches Distributors List

Table 74. Buprenorphine Transdermal Patches Customer List

Table 75. Global Buprenorphine Transdermal Patches Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Buprenorphine Transdermal Patches Sales Market Forecast by Region

Table 77. Global Buprenorphine Transdermal Patches Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Buprenorphine Transdermal Patches Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Buprenorphine Transdermal Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Buprenorphine Transdermal Patches Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Buprenorphine Transdermal Patches Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Buprenorphine Transdermal Patches Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Buprenorphine Transdermal Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Buprenorphine Transdermal Patches Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Buprenorphine Transdermal Patches Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Buprenorphine Transdermal Patches Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Buprenorphine Transdermal Patches Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Buprenorphine Transdermal Patches Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Buprenorphine Transdermal Patches Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Buprenorphine Transdermal Patches Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Buprenorphine Transdermal Patches Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Buprenorphine Transdermal Patches Revenue Market Share Forecast by Application (2023-2028)

Table 95. Grunenthal Basic Information, Buprenorphine Transdermal Patches Manufacturing Base, Sales Area and Its Competitors

Table 96. Grunenthal Buprenorphine Transdermal Patches Product Offered

Table 97. Grunenthal Buprenorphine Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Grunenthal Main Business

Table 99. Grunenthal Latest Developments

Table 100. PurduePharma Basic Information, Buprenorphine Transdermal Patches Manufacturing Base, Sales Area and Its Competitors

Table 101. PurduePharma Buprenorphine Transdermal Patches Product Offered

Table 102. PurduePharma Buprenorphine Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. PurduePharma Main Business

Table 104. PurduePharma Latest Developments

Table 105. Luye Pharma Basic Information, Buprenorphine Transdermal Patches Manufacturing Base, Sales Area and Its Competitors

Table 106. Luye Pharma Buprenorphine Transdermal Patches Product Offered

Table 107. Luye Pharma Buprenorphine Transdermal Patches Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Luye Pharma Main Business

Table 109. Luye Pharma Latest Developments

List of Figures

Figure 1. Picture of Buprenorphine Transdermal Patches

Figure 2. Buprenorphine Transdermal Patches Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Buprenorphine Transdermal Patches Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Buprenorphine Transdermal Patches Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Buprenorphine Transdermal Patches Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 5mcg/h

Figure 10. Product Picture of 7.5mcg/h

Figure 11. Product Picture of 10mcg/h

Figure 12. Product Picture of 15 mcg/h

Figure 13. Product Picture of 20 mcg/h

Figure 14. Global Buprenorphine Transdermal Patches Sales Market Share by Type in 2021

Figure 15. Global Buprenorphine Transdermal Patches Revenue Market Share by Type (2017-2022)

Figure 16. Buprenorphine Transdermal Patches Consumed in Relieve Cancer Pain

Figure 17. Global Buprenorphine Transdermal Patches Market: Relieve Cancer Pain (2017-2022) & (K Units)

Figure 18. Buprenorphine Transdermal Patches Consumed in Other

Figure 19. Global Buprenorphine Transdermal Patches Market: Other (2017-2022) & (K Units)

Figure 20. Global Buprenorphine Transdermal Patches Sales Market Share by Application (2017-2022)

Figure 21. Global Buprenorphine Transdermal Patches Revenue Market Share by Application in 2021

Figure 22. Buprenorphine Transdermal Patches Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Buprenorphine Transdermal Patches Revenue Market Share by Company in 2021

Figure 24. Global Buprenorphine Transdermal Patches Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Buprenorphine Transdermal Patches Revenue Market Share by Geographic Region in 2021

Figure 26. Global Buprenorphine Transdermal Patches Sales Market Share by Region (2017-2022)

Figure 27. Global Buprenorphine Transdermal Patches Revenue Market Share by Country/Region in 2021

Figure 28. Americas Buprenorphine Transdermal Patches Sales 2017-2022 (K Units)

Figure 29. Americas Buprenorphine Transdermal Patches Revenue 2017-2022 ($ Millions)

Figure 30. APAC Buprenorphine Transdermal Patches Sales 2017-2022 (K Units)

Figure 31. APAC Buprenorphine Transdermal Patches Revenue 2017-2022 ($ Millions)

Figure 32. Europe Buprenorphine Transdermal Patches Sales 2017-2022 (K Units)

Figure 33. Europe Buprenorphine Transdermal Patches Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Buprenorphine Transdermal Patches Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Buprenorphine Transdermal Patches Revenue 2017-2022 ($ Millions)

Figure 36. Americas Buprenorphine Transdermal Patches Sales Market Share by Country in 2021

Figure 37. Americas Buprenorphine Transdermal Patches Revenue Market Share by Country in 2021

Figure 38. United States Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Buprenorphine Transdermal Patches Sales Market Share by Region in 2021

Figure 43. APAC Buprenorphine Transdermal Patches Revenue Market Share by Regions in 2021

Figure 44. China Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Buprenorphine Transdermal Patches Sales Market Share by Country in 2021

Figure 51. Europe Buprenorphine Transdermal Patches Revenue Market Share by Country in 2021

Figure 52. Germany Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Buprenorphine Transdermal Patches Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Buprenorphine Transdermal Patches Revenue Market Share by Country in 2021

Figure 59. Egypt Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Buprenorphine Transdermal Patches Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Buprenorphine Transdermal Patches in 2021

Figure 65. Manufacturing Process Analysis of Buprenorphine Transdermal Patches

Figure 66. Industry Chain Structure of Buprenorphine Transdermal Patches

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390